AstraZeneca boosts CEO Soriot's pay to about $24 million for 2025

Core Viewpoint - AstraZeneca CEO Pascal Soriot's pay for 2025 has increased by 6.4% to approximately $24 million, primarily due to higher annual bonuses, maintaining his position among the highest-paid executives in the FTSE 100 [1]. Group 1: CEO Compensation - Pascal Soriot's total pay for 2025 is reported at 17.7 million pounds ($23.87 million) [1]. - The annual bonus for Soriot reached 4.3 million pounds, reflecting a 22% increase from the previous year [1]. Group 2: Company Performance - AstraZeneca is noted as London's most valuable company, with a significant increase in earnings reported for 2025 [1].